Dear Pan African Association of Surgeons,
We are writing to you during this difficult time asking for your help with CovidSurg dissemination among your members and surgical network. COVID-19 is a rapidly expanding global challenge, placing a huge burden on healthcare systems. There is no current evidence to inform the management of surgical patients during this pandemic. Capturing real-world data and sharing international experience will support the management of this complex group of patients.
We would like to invite your members to join CovidSurg, an international collaboration of >2800 surgeons and anaesthetists across 115 countries. To this date, we have launched 2 modelling studies and 2 cohort studies.
Modelling studies aim to inform surgical resources and team planning:
- Surgical team model: to estimate how many surgeons get infected by COVID-19 and the impact of surgeons' sickness on surgical care delivery. Please contribute here: (https://is.gd/covidsurgsurvey2)with real-world data from your team. (Italian version: https://is.gd/surveyitalian) (Spanish version: https://is.gd/surveyspanish).
- Elective cancellations model:currently under analysis.
Cohort studies aim to evaluate surgical patients management and outcomes:
- CovidSurg cohort study: will capture the outcomes of surgery for patients who have COVID-19 infection. It will include patients undergoing ANY type of surgery, who are diagnosed with COVID-19 infection at the time of surgery or within 30 days. Data can be collected either retrospectively or prospectively. For details and docs: https://globalsurg.org/cancercovidsurg/.
- Cancer-CovidSurg: will include all cancer patients with a tumor board decision for surgery (both operated and non-operated patients, COVID +ve and COVID -ve are included). This study aims to determine outcomes for patients who are operated during the pandemic, but also for the ones who have delayed surgery or alternative treatment. Participating centres can include one or more of these cancer types: Colorectal, Oesophagogastric, Head and neck, Lung, Liver, Pancreatic, Sarcoma, Kidney, Bladder, Prostate, Uterine, Ovarian and Breast. For details and docs: https://globalsurg.org/cancercovidsurg/.
To get involved, please register at: http://tiny.cc/covidsurg. Authorship will follow the GlobalSurg / ESCP Cohort Studies model, with all collaborators will be recognised with PubMed-indexed collaborative co-authorship (example:https://pubmed.ncbi.nlm.nih.gov/29452941/).
If you have any questions, please get in touch with us at: email@example.com.
Thank you for considering joining the CovidSurg collaboration and we look forward to collaborating with you.
On behalf of the CovidSurg Collaborative